(2021). Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: CD3xCD19 DART Molecule Treatment Induces Non-apoptotic Killing and Is Efficient Against High-risk Chemotherapy and Venetoclax-resistant Chronic Lymphocytic Leukemia Cells. BMJ Publishing Group, 2021.
MLA (8th ed.) CitationCorrection: CD3xCD19 DART Molecule Treatment Induces Non-apoptotic Killing and Is Efficient Against High-risk Chemotherapy and Venetoclax-resistant Chronic Lymphocytic Leukemia Cells. BMJ Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.